Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), bought 103,674 shares at $5.97 ($619K) on 2023-11-29, disclosed to the SEC on 2023-12-01.
Open-market purchase of $619k YMAB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.97 | 51,837 | $309K | 50.0% |
| 2 | $5.97 | 51,837 | $309K | 50.0% |
| Total | $5.97 avg | 103,674 | $619K | 100% |
| Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |
| YMAB | SELL | 2021-06-11 | $812K | — | Filing → |